Brind.

Ligand Pharmaceuticals Announces Annual Investor Day for December 2026

1 report, 1 independent Updated Oct 1

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Ligand Pharmaceuticals announced its annual Investor Day, scheduled for Tuesday, December 8, 2026, at the Harvard Club of New York City. The event will feature presentations from Ligand CEO Todd Davis and CFO Tavo Espinoza, covering the company’s strategy, investment activity, and long-term financial outlook. Wes Kaupinen, Founder and CEO of Palvella Therapeutics, will also attend to discuss the progress of QTORIN™ rapamycin.

From manilatimes.net

Why it matters

Some supportBrind's analysis of the reports

As a leading royalty aggregator, Ligand Pharmaceuticals partners with biopharmaceutical companies to finance late-stage clinical development programs. The Investor Day provides insight into the company’s portfolio management and financial strategy within the biopharma industry.

From manilatimes.net

Who's involved

Ligand PharmaceuticalsBiopharmaceutical company that aggregates royalties and finances clinical development programs
Todd DavisCEO of Ligand Pharmaceuticals

Keep exploring

The entities involved

New York City
most populous city in the United States
- A play was noted for referencing travel to New York City.00:51
- High cost of living reported in major areas, including New York City and Northern Colorado.00:24
Todd Davis
American businessman

Nothing else this week.

Related events

Lifetime Brands, Inc. hosted its Investor Day in New York City on October 1, 2026.Oct 22

Coverage

Newest first; wire copies grouped

Oct 1manilatimes.net